Anna Protopapas

Anna Protopapas serves as President and CEO at Mersana Therapeutics. Mersana Therapeutics operates in the research sector with approximately 150.0 employees. The company is headquartered in Cambridge, Massachusetts. Mersana Therapeutics generates annual revenue of 40500000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 2 executives at Mersana Therapeutics.
• • 3,781 executive contacts are available in Massachusetts.
• • Our database includes 201,469 c suite-level executives.

Mimecast Google Cloud Hosting New Relic WordPress.org Mobile Friendly Vimeo Google Analytics Google Font API Nginx Google Tag Manager Remote AI

cancer research antibody drug conjugates drug development bioconjugation oncology biotechnology life sciences biotechnology: pharmaceutical preparations health care biotechnology research antibody-drug conjugates adcs cancer therapeutics dolasynthen immunosynthen pipeline development cytotoxic payloads immunostimulatory drugs drug optimization target antigen novel cancer therapies onco-targeting b7-h4 her2 target personalized medicine clinical trials oncology drug development collaborative research biopharmaceutical innovation patient-centric solutions cancer treatment drug delivery systems biologics targeted therapy clinical-stage scientific excellence regulatory affairs medical advancements therapeutic windows reduced toxicity life-changing therapies multi-pronged strategy stakeholder engagement cancer care research & development commercialization biotech industry scientific advisory board patient access diversity & inclusion corporate responsibility sustainability efforts community engagement healthcare innovation biopharmaceutical immunostimulatory payloads novel therapies targeted therapies solid tumors her2-negative breast cancer triple-negative breast cancer innovative technology patient-centric strategic partnerships merck kgaa gsk takeda johnson & johnson unmet medical needs patient demographics global expansion scientific innovation fleximer platform therapeutic efficacy safety profiles collaboration transformative therapies patient outcomes hospital & health care health wellness & fitness

TL

Timothy Lowinger Chief Science & Technology Officer at Mersana Therapeutics

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

How can I contact Anna Protopapas?

Anna Protopapas's verified email address is available on MessageCEO. They currently work at Mersana Therapeutics. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Anna Protopapas lead?

Anna Protopapas is President and CEO at Mersana Therapeutics, a company in the research sector with 150.0 employees. The company is based in Cambridge, Massachusetts.

What industry is Anna Protopapas in?

Anna Protopapas works in the research industry as President and CEO at Mersana Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Anna Protopapas's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Anna Protopapas's profile is kept up-to-date with the latest available information.

Last updated: April 22, 2026